| 1 |
34322387 | Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells. | 2021 |
1 |
| 2 |
34678222 | DFF40 deficiency in cancerous T cells is implicated in chemotherapy drug sensitivity and resistance through the regulation of the apoptotic pathway. | 2021 Dec |
1 |
| 3 |
28947136 | BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis. | 2018 Jan 1 |
2 |
| 4 |
22617334 | Phospho-Bcl-x(L)(Ser62) plays a key role at DNA damage-induced G(2) checkpoint. | 2012 Jun 1 |
1 |
| 5 |
22072718 | Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis. | 2011 Dec 30 |
1 |
| 6 |
19488402 | IKKalpha and IKKbeta regulation of DNA damage-induced cleavage of huntingtin. | 2009 Jun 2 |
1 |
| 7 |
19726787 | Live-cell imaging of caspase activation for high-content screening. | 2009 Sep |
1 |
| 8 |
18071312 | Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells. | 2008 May 15 |
1 |
| 9 |
18758060 | Differential regulation of the antiapoptotic action of B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma extra long (Bcl-xL) by c-Jun N-terminal protein kinase (JNK) 1-involved pathway in neuroglioma cells. | 2008 Sep |
2 |
| 10 |
16960866 | NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line. | 2006 Dec |
2 |
| 11 |
15657350 | (-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance. | 2005 Jan |
1 |
| 12 |
15674333 | Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. | 2005 Mar 17 |
1 |
| 13 |
14745596 | Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins. | 2004 Feb |
1 |
| 14 |
12618199 | Etoposide-mediated sensitization of squamous cell carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced loss in mitochondrial membrane potential. | 2003 Apr |
1 |
| 15 |
11815602 | Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis. | 2002 Apr 5 |
1 |
| 16 |
11929841 | Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents. | 2002 Apr 1 |
1 |
| 17 |
12553012 | Differential effect of Bcl-xl over-expression on cell death of the monocytic leukemia cell line U937. | 2002 Nov-Dec |
2 |
| 18 |
11260076 | In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID/NOD-Hu model. | 2001 Mar |
4 |
| 19 |
11346470 | Co-transduction of Apaf-1 and caspase-9 augments etoposide-induced apoptosis in U-373MG glioma cells. | 2001 Apr |
1 |
| 20 |
11431014 | Resistance of CD4-positive T lymphocytes to etoposide-induced apoptosis mediated by upregulation of Bcl-xL expression in patients with HTLV-I-associated myelopathy. | 2001 Jul 2 |
1 |
| 21 |
10620629 | Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors. | 2000 Jan 5 |
4 |
| 22 |
10839193 | Differential responses of Bcl-2 family genes to etoposide in chronic myeloid leukemia K562 cells. | 2000 Mar |
3 |
| 23 |
10850456 | Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. | 2000 Jun 1 |
1 |
| 24 |
10918609 | Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. | 2000 Jul 20 |
1 |
| 25 |
10050882 | Bcl-2 overexpression results in reciprocal downregulation of Bcl-X(L) and sensitizes human testicular germ cell tumours to chemotherapy-induced apoptosis. | 1999 Feb 18 |
1 |
| 26 |
10381626 | Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells. | 1999 Apr |
1 |
| 27 |
10732782 | Survival signals within the tumour microenvironment suppress drug-induced apoptosis: lessons learned from B lymphomas. | 1999 Mar |
1 |
| 28 |
9570926 | Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities. | 1998 Apr 10 |
1 |
| 29 |
9699642 | "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. | 1998 Aug 1 |
3 |
| 30 |
9494534 | Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. | 1997 Nov-Dec |
1 |
| 31 |
8663611 | Activation of the CPP32 apoptotic protease by distinct signaling pathways with differential sensitivity to Bcl-xL. | 1996 Jul 26 |
1 |
| 32 |
8798452 | Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL. | 1996 Sep 13 |
1 |
| 33 |
8840993 | Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. | 1996 Oct 15 |
1 |
| 34 |
7655019 | Expression of bcl-xL can confer a multidrug resistance phenotype. | 1995 Sep 1 |
1 |